Health
Anti-phospholipid antibodies in severely ill patients not distinctive to COVID-19, says study – News-Medical.Net
A new study by researchers at the University of Toronto and the University of Calgary in Canada indicates that the presence of these antibodies correlates with…
Recent research indicates the occurrence of thromboembolic complications involving anti-phospholipid antibodies (APLA) and the anti-phospholipid syndrome (APS) in severe coronavirus disease 2019 (COVID-19). However, conflicting reports have emerged.
A new study by researchers at the University of Toronto and the University of Calgary in Canada indicates that the presence of these antibodies correlates with more severe COVID-19 symptoms and signs.
The team have released their findings as a preprint…
-
Noosa News20 hours agoWoman was watching keepers work when lion attacked, Darling Downs Zoo says
-
Noosa News19 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
General23 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline
-
General23 hours agoDisloyal far-left breakaways are coming for Labor